CanCan Body Composition Study
Cancan
1 other identifier
observational
40
1 country
1
Brief Summary
The aim of this study is to develop a dataset with reference body composition measurements using criterion methods. This dataset will be used to develop new protocols to study patients with cancer. Obtaining measurements of sodium bromide (NaBr), deuterium dilution (D2O), and D3-Creatine in a stratified sample of adults will determine the accuracy (and precision) of the available devices for ECW, TBW, and skeletal muscle mass measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
ExpectedDecember 26, 2025
December 1, 2025
6 months
December 12, 2025
December 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Skeletal Muscle Mass
Muscle mass
Single time point
Study Arms (1)
Cross-sectional group
20 young (20-40yo) and 20 older (70+) adults
Eligibility Criteria
The participants will be community dwelling, have a self-reported ability to walk one-quarter of a mile and climb 10 steps without difficulty, self-reported ability to perform activities of daily living (ADLs) without difficulty, and no life-threatening conditions or diseases that would alter their body composition from what is typical for their age, sex, and BMI. Overall, participants must be ambulatory, able to withstand lying flat on the DXA table for up to 10 minutes, stand without aid for 2 minutes, weigh less than 440 lbs and be in generally good health.
You may qualify if:
- Being either male or female
- Being an adult \>20 - \<40 or \>70 years of age.
- Having a body weight of less than 440 pounds
- Being willing to comply with the study procedures
- Not having a chronic illness (e.g., diabetes, cancer, etc.)
- Must be willing to have biospecimens and imaging stored for research use
You may not qualify if:
- Being pregnant, attempting to become pregnant, or breastfeeding
- Having medical implants such as a pacemaker or metal joint replacements
- Having had a mastectomy, breast reduction, or breast implants
- Having hair that cannot fit in a swim cap
- Having a body weight greater than 440 pounds
- Taking medications that alter the body's fluid compartments (ex: diuretics)
- Not willing to have biospecimens and imaging stored for future research use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Boyd Professor
Study Record Dates
First Submitted
December 12, 2025
First Posted
December 26, 2025
Study Start
October 15, 2025
Primary Completion
April 15, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
December 26, 2025
Record last verified: 2025-12